Recurrent Fetal Losses and Autoantibody: Successful Treatment with Intravenous Immunoglobulin.

Ryu, H M; Kim, M Y; Kim, E S; Noh, G W; Jang, H C; Jun, J Y

Search: Korean J Obstet Gynecol Search

CLOSE

Obstet Gynecol Sci > Volume 41(8); 1998 > Article

Case Report

Korean Journal of Obstetrics & Gynecology 1998;41(8):2229-2232.
Published online: January 1, 2001

Recurrent Fetal Losses and Autoantibody: Successful Treatment with Intravenous Immunoglobulin.

H M Ryu, M Y Kim, E S Kim, G W Noh, H C Jang, J Y Jun

Abstract

There is an association between the presence of autoantibody and the occurrence of repeated second trimester fetal losses. Many uncontrolled studies have reported with steroids, low dose aspirin, heparin, or their combination. Also, treatment failures have been reported with most of these therapeutic regimens. Immunoglobulins play a central role in immune regulation. We present a successful outcome by intravenous immunoglobulines in pregnant women with previous recurrent second trimester fetal losses and autoantibody with a brief review of the literatures.

Keywords: Autoantibody; Recurrent second trimester fetal loss; Intravenous immunoglobulin

TOOLS

Full text via DOI
Download Citation

Share :

METRICS

1,386 View
10 Download

Related articles in Obstet Gynecol Sci

A Case of Successful Pregnancy in a Woman with Anti-M Isoimmunization after Intravenous Immunoglobulin Therapy.1998 November;41(11)

Prevalence of Autoantibodies in Patients with Endometriosis.2001 May;44(5)

A Change of Peripheral CD56+Natural Killer Cell Fraction in Recurrent Pregnancy Loss Patients who Successfully Treated with Intravenous Immunoglobulin in Previous Pregnancy.2004 October;47(10)

ABOUT

ARTICLE & TOPICS

Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES

POLICY

FOR CONTRIBUTORS

Editorial Office: 4th Floor, 36 Gangnam-daero 132-gil, Gangnam-gu, Seoul 06044, Korea.
Tel: +82-2-2271-6788 Fax: +82-2-3445-2440 E-mail: journal@ogscience.org